JAX Tech Talk: Let’s Talk iPSC Disease Models as a Tool in Drug Discovery

Induced pluripotent stem cell (iPSC) technology has been greatly enhanced since its discovery by Yamanaka in 2006. Significant
improvements in generating, differentiating, and gene-editing of iPSCs have contributed to the increased versatility and effectiveness
of iPSC models used in a variety of preclinical research applications.
During this JAX Tech Talk, Dr. Steven Rodriguez, Lab Head of the Rare & Neurological Diseases Therapeutic Area at Sanofi, will discuss
how his group uses iPSC models to understand disease biology and then leverages resulting data and insights to identify new drug
targets. He also will review steps critical for developing iPSC models, including iPSC line selection, characterization, and phenotyping